MBRX
Moleculin Biotech, Inc.
$4.28
Earnings Summary
Revenue | $0Mn |
Net Profits | $-10.27Mn |
Net Profit Margins | -Inf% |
Highlights
Moleculin Biotech, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Moleculin Biotech, Inc. has generated NaN% jump in its revenue since last 3-months.
Moleculin Biotech, Inc.’s net profit fell -82.46% since last year same period to $-10.27Mn in the Q4 2023. On a quarterly growth basis, Moleculin Biotech, Inc. has generated -83.08% fall in its net profits since last 3-months.
Moleculin Biotech, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Moleculin Biotech, Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Moleculin Biotech, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -3.53 |
EPS Estimate Current Year | -3.53 |
Highlights
Moleculin Biotech, Inc.’s earning per share (EPS) estimates for the current quarter stand at -3.53 - a -15.74% fall from last quarter’s estimates.
Moleculin Biotech, Inc.’s earning per share (EPS) estimates for the current year stand at -3.53.
Key Ratios
Key ratios of the Moleculin Biotech, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -5.02 |
Highlights
Moleculin Biotech, Inc.’s earning per share (EPS) fell -2082.61% since last year same period to -5.02 in the Q4 2023. This indicates that the Moleculin Biotech, Inc. has generated -2082.61% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-10 | -0.25 | -0.28 | -12% |
2023-11-13 | -3.55 | -2.85 | 19.72% |
2024-03-22 | -3.05 | -5.02 | -64.59% |
2023-08-10 | -0.27 | -0.2 | 25.93% |
₹0 US Stocks a/c Opening Fee